Impurity deficiencies in submissions are remarkably consistent. Subathra Ramamoorthy, Veranova, explains how to catch them before agency filing.
News|Articles|June 1, 2020
- Pharmaceutical Technology\'s In the Lab eNewsletter-06-03-2020
- Volume 15
- Issue 6
Avantor OmniTop Sample Tubes Offers Adjustable Volume Sampling
Author(s)Pharmaceutical Technology Editors
The company recently launched its OmniTop Sample Tubes adjustable volume sampling system, a single-use system that allows for exact sampling.
Advertisement
Avantor’s recently launched OmniTop Sample Tubes adjustable volume sampling system (AVSS) is a single-use system that allows for exact sampling in cell and gene therapy production. The system allows for precise small volume samples, which is expected to streamline the bioprocessing sampling process with increased efficiency, reduced volume loss, and lowered contamination risk.
AVSS is designed to precisely collect small-volume samples from the sterile process. It helps eliminate volume loss in the connection lines, making it ideal for critical and high-value product sampling in applications including:
- cell and gene therapy processes
- final fill operations
- glass and single-use bioreactor sampling
The system can used as a single point solution or can be custom configured into manifold designs. It offers volume ranges of 0.5–15.0 mL, allowing for sample collection of only what is needed for analytical testing to meet the exact needs of the process.
Source: Avantor
Articles in this issue
over 6 years ago
New SARS-CoV-2 Molecular Quality Controlover 6 years ago
Bio-Rad Launches Anti-Certolizumab Pegol Antibodiesover 6 years ago
Improved Pharma to Expand its Microscopy Servicesover 6 years ago
Good Automation Practices in the Laboratoryover 6 years ago
Contamination Drives a More Concerted Approach to Genotoxinsover 6 years ago
Testing for Nitrosamines in Pharmaceutical DrugsAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on how forced degradation and trace impurity profiling in potent APIs shape regulator-ready analytical methods.
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF in Tarrytown, spoke with PharmTech at AAPS PharmSci 360 about formulation and characterization challenges for amorphous solid dispersions.
FDA draft guidance on individualized genome editing lets BLAs add patient-specific variants without new trials, shifting evidence to CMC assay data.
Vibha Jawa, PhD, chief scientific officer at EpiVax, explains why the need for animal studies varies by modality and what it takes for organ-on-chip and other human-relevant models to replace these studies in IND-enabling toxicology work.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI
2
Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026
3
AAPS PharmSci 360: How USP Is Tackling the Novel Excipient Roadblock
4
Why Drug Shortages Average 5+ Years: PharmTech Explained
5